Vita34 ApS: Financial statements 2012
CVR: 27511759
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
Vita34 ApS (CVR 27511759) has filed annual accounts for 2012. In 2012, the company reported revenue of DKK 5,294,144 and a net result of DKK 929,516. The profit margin was 17.6%. Equity in the 2012 report amounted to DKK 2,193,315. The solvency ratio was 6.9%.
- Revenue
- DKK 5,294,144
- Gross Profit
- DKK 4,561,720
- Profit/Loss
- DKK 929,516
- Equity
- DKK 2,193,315
- Total Assets
- DKK 31,998,185
Official annual report
Keep an eye on Vita34 ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of December 31, 2012, ALBERT PEDERSEN. STATSAUTORISEREDEREVISORER I/S has stepped down as auditor of Vita34 ApS.
About Vita34 ApS
Vita34 ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2004. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The company was previously named StemCare ApS and BIOBANK DANMARK ApS. The management consists of Marion Bartel and Vivien Weise. The company is owned by FamiCord AG. The company has 2 employees (2018). In 2025, the company reported a gross profit of DKK 3,842,095 and a net result of DKK 1,034,065 compared with DKK 1,030,138 the year before. Equity in the 2025 report amounted to DKK 5,982,880.